We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
-25.13%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$97.5B
AUM Growth
-$45.1B
Cap. Flow
-$1.57B
Cap. Flow %
-1.61%
Top 10 Hldgs %
35.7%
Holding
526
New
28
Increased
112
Reduced
187
Closed
33

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$691M
2
MELI icon
Mercado Libre
MELI
+$341M
3
SPOT icon
Spotify
SPOT
+$335M
4
WIX icon
WIX.com
WIX
+$315M
5
RBLX icon
Roblox
RBLX
+$233M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$334M
2
CBRE icon
CBRE Group
CBRE
+$310M
3
AMZN icon
Amazon
AMZN
+$302M
4
NVDA icon
NVIDIA
NVDA
+$296M
5
TTD icon
Trade Desk
TTD
+$255M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.49%
2 Healthcare 25.5%
3 Technology 17.13%
4 Communication Services 10.66%
5 Financials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SILK
426
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$9K ﹤0.01%
235
– –
SRNE
427
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$9K ﹤0.01%
4,314
– –
ACAD icon
428
Acadia Pharmaceuticals
ACAD
$5.03B
$8K ﹤0.01%
544
– –
CERS icon
429
Cerus
CERS
$474M
$8K ﹤0.01%
1,459
+316
+28% +$1.58K
LBRDK icon
430
Liberty Broadband Class C
LBRDK
$5.15B
$8K ﹤0.01%
70
– –
NTNX icon
431
Nutanix
NTNX
$16.9B
$8K ﹤0.01%
563
– –
PLL
432
DELISTED
Piedmont Lithium
PLL
$8K ﹤0.01%
212
– –
ATEX icon
433
Anterix
ATEX
$1.94B
$7K ﹤0.01%
162
– –
BMRN icon
434
BioMarin Pharmaceuticals
BMRN
$12.4B
$7K ﹤0.01%
82
– –
COLM icon
435
Columbia Sportswear
COLM
$2.94B
$7K ﹤0.01%
95
– –
HI
436
DELISTED
Hillenbrand
HI
$7K ﹤0.01%
170
– –
LSPD icon
437
Lightspeed Commerce
LSPD
$1.35B
$7K ﹤0.01%
310
– –
MATV icon
438
Mativ Holdings
MATV
$711M
$7K ﹤0.01%
265
– –
NVAX icon
439
Novavax
NVAX
$1.31B
$7K ﹤0.01%
130
– –
RARE icon
440
Ultragenyx Pharmaceutical
RARE
$2.55B
$7K ﹤0.01%
115
– –
VUZI icon
441
Vuzix
VUZI
$224M
$7K ﹤0.01%
924
– –
WSM icon
442
Williams-Sonoma
WSM
$29.6B
$7K ﹤0.01%
126
– –
NVRO
443
DELISTED
NEVRO CORP.
NVRO
$7K ﹤0.01%
154
– –
FOLD
444
DELISTED
Amicus Therapeutics
FOLD
$6K ﹤0.01%
538
– –
BLNK icon
445
Blink Charging
BLNK
$87.9M
$5K ﹤0.01%
327
-73
-18% -$1.37K
CSTL icon
446
Castle Biosciences
CSTL
$979M
$5K ﹤0.01%
225
– –
CVGW
447
DELISTED
Calavo Growers
CVGW
$5K ﹤0.01%
113
– –
KYNB
448
Kyntra Bio
KYNB
$29.4M
$5K ﹤0.01%
19
– –
LASR icon
449
nLIGHT
LASR
$3.17B
$5K ﹤0.01%
468
– –
MASS icon
450
908 Devices
MASS
$364M
$5K ﹤0.01%
249
– –
16 17
18
19 20

Similar funds

National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Baillie Gifford & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Baillie Gifford & Co held 526 positions worth $97.5B, down 32% from $143B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Baillie Gifford & Co's Q2 2022 filing shows 28 new, 112 increased, 187 reduced and 33 closed positions. Its largest new stake was Hershey: 94,977 shares worth $20.4M. The largest sale was Tesla, an estimated $334M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q2 2022 buy was Hershey: 94,977 shares worth $20.4M.
  • Baillie Gifford & Co added most to Royalty Pharma in Q2 2022, an estimated $691M increase.
  • Baillie Gifford & Co's biggest Q2 2022 reduction was Tesla, cutting an estimated $334M.
  • Baillie Gifford & Co fully exited iShares Silver Trust in Q2 2022, selling an estimated $21.2M.
  • Baillie Gifford & Co's ten largest holdings make up 36% of its $97.5B portfolio in Q2 2022.
  • Baillie Gifford & Co opened 28 new positions and closed 33 in Q2 2022.
  • Baillie Gifford & Co's portfolio value fell 32% quarter-over-quarter to $97.5B.

Based on Baillie Gifford & Co's 13F filing for Q2 2022, filed 8 Aug 2022.